Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009503 220012077 0 59.9 Curative (C) 2017-06-03 2017-06-16 Alemtuzumab cond (RI ALLO CAMP100) 02 N 220006368 MITOXANTRONE
220009504 220012077 1.67 73.999 null null 2016-05-21 Cisplatin null null 220006368 UKALL XII
220009505 220012077 1.82 72.85 Curative (C) 2019-01-08 2019-01-08 Cisplatin + Pemetrexed 2 Y 220006368 PACLITAXEL
220009506 220012077 1.63 61.1 Palliative (P) 2017-10-16 2017-10-16 IDARUBICIN N N 220006368 MERCAPTOPURINE
220009507 220012077 1.58 51.9 Curative (C) 2018-06-17 2018-06-24 IDARUBICIN + MITOXANTRONE + Tretinoin N N 220006368 ATG + BUSULFAN + FLUDARABINE
220009508 220003870 null null Curative (C) null 2015-06-12 Pentostatin null null 220008837 METHOTREXATE INTRATHECAL
220009509 220003871 1.67 68.8 null 2016-01-13 2016-01-13 ALL UKALL2011 Maintenance B4 02 N 220008953 RUXOLITINIB
220009510 220003872 1.63 82.9 Curative (C) 2013-08-07 2013-08-09 CISPLATIN + ETOPOSIDE 2 null 220009544 BOSUTINIB
220009511 220003873 1.77 16.8 Curative (C) 2014-06-27 2014-06-28 TOPARP TRIAL 02 N 220010013 BOSUTINIB
220009512 220012078 null 68.05 Disease modification (D) 2017-10-11 2017-10-31 Capecitabine N null 220010069 CYTARABINE INTRATHECAL
220009513 220012078 1.8 64.5 Disease modification (D) null 2018-02-14 Doxorubicin 75mg/m2 N Y 220010069 DABRAFENIB + TRAMETINIB
220009514 220003874 1.55 0 Disease modification (D) 2017-07-17 2017-07-17 OCTREOTIDE 02 N 220010837 BOSUTINIB
220009515 220003875 1.94 null Curative (C) 2015-03-18 2015-03-18 BEP 3 day 02 N 220011016 TRIPLE INTRATHECAL
220009516 220003876 1.8 0 Curative (C) null 2015-12-30 Cisplatin + Pemetrexed N N 220012398 FLUDARABINE + MELPHALAN
220009517 220003877 null null Curative (C) 2015-12-21 2015-12-28 Triple / Double Intrathecal Therapy N N 220012731 TRIPLE INTRATHECAL
220009518 220003877 1.77 68 Curative (C) 2017-12-01 2017-12-02 Alemtuzumab+Busulfan+CyclophosphMUD 02 N 220012731 FLUDARABINE + MELPHALAN
220009519 220003877 0 null Palliative (P) 2017-05-29 2017-12-12 CHOP R - 21 days N N 220012731 LENALIDOMIDE
220009520 220003877 null 46.7 null 2014-08-22 2014-08-25 Fludarabine + Melphalan RIC Allo N N 220012731 FLUOROURACIL
220009521 220003878 1.57 0 Curative (C) 2016-06-13 2016-06-14 DABRAFENIB + TRAMETINIB 01 N 220013190 TRIPLE INTRATHECAL
220009522 220003879 1.5 72.1 Palliative (P) 2015-11-10 2015-11-11 Cisplatin + Pemetrexed 02 N 220013384 IRINOTECAN + MDG
220009523 220012080 0 58.6 Curative (C) null 2018-06-27 CAPECITABINE + EPIRUBICIN + OXALIPLATIN null null 220014128 FLUDARABINE + MELPHALAN
220009524 220012080 1.63 85.5 Radical (R) 2015-04-17 2015-04-17 Cyclophosphamide TBI Allograft N null 220014128 LANREOTIDE
220009525 220003880 0 8.7 Curative (C) 2016-03-26 2016-04-02 Sorafenib 02 N 220014290 CYTARABINE + MITOXANTRONE
220009526 220012081 1.84 94.8 Palliative (P) 2014-09-30 2014-09-30 Vemurafenib 02 N 220014509 BUSULPHAN
220009527 220003881 null 170 null null 2014-12-09 Mitox + Tretinoin Spanish Course 3 2 N 220014919 CISPLATIN + PEMETREXED
220009528 220003881 1.7 59.9 Curative (C) 2018-08-31 2018-08-31 Cytarabine intrathecal 2 null 220014919 FBC
220009529 220003881 1.68 0 Curative (C) 2018-03-29 2018-03-29 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220014919 MITOXANTRONE
220009530 220003881 1.66 0 Curative (C) 2016-03-25 2016-05-02 FEC + DOCETAXEL N N 220014919 IDARUBICIN + MITOXANTRONE + TRETINOIN
220009531 220003881 1.78 63.2 Disease modification (D) 2018-10-04 2018-10-04 NHL 2003 Gp B COP N N 220014919 BUSULPHAN
220009532 220003882 1.75 null Adjuvant (A) 2016-08-18 2016-08-28 ALL UKALL2011 Maintenance B4 N N 220016351 CHLORAMBUCIL + OFATUMUMAB
220009533 220003883 null 97.5 Adjuvant (A) 2018-01-16 2018-01-16 ECF N Y 220016525 BEVACIZUMAB
220009534 220003884 null 121 Curative (C) 2017-04-05 2017-04-05 MITOXANTRONE + TRETINOIN N N 220016581 FLUDARABINE + MELPHALAN
220009535 220003885 1.68 0 Curative (C) null 2016-10-03 DAUNORUBICIN N N 220016621 IDARUBICIN
220009536 220003885 null null null null 2013-07-30 Paclitaxel 7 day null null 220016621 CHLORAMBUCIL + OBINUTUZUMAB
220009537 220003886 1.79 null Curative (C) 2015-04-06 2015-04-21 IPILIMUMAB + NIVOLUMAB 02 N 220016746 CYTARABINE + FLUDARABINE + IDARUBICIN
220009538 220003887 1.74 null null 2016-05-24 2016-05-24 Fludarabine + Melphalan RIC Allo N N 220017143 UKALL XII
220009539 220003888 1.73 57 Curative (C) 2016-11-20 2016-11-30 CISPLATIN + ETOPOSIDE 02 N 220017507 FLUDARABINE + MELPHALAN
220009540 220003889 1.74 70.8 Curative (C) 2014-11-15 2014-11-15 Busulfan Oral 02 N 220017610 ARSENIC TRIOXIDE + TRETINOIN
220009541 220003890 1.71 100 null null 2013-06-26 Arsenic Trioxide (consolidation) null null 220017673 METHOTREXATE INTRATHECAL
220009542 220003891 1.75 94.1 Palliative (P) 2015-05-14 2015-05-14 DABRAFENIB + TRAMETINIB 2 N 220018110 DACARBAZINE
220009543 220003891 1.55 73.95 Curative (C) 2016-02-09 2016-04-03 CVP R 2 N 220018110 FLA
220009544 220003891 1.76 135.3 Palliative (P) 2015-11-18 2015-11-25 Arsenic Triox + Tretinoin Ind W1-4 N N 220018110 DABRAFENIB + TRAMETINIB
220009545 220003892 1.78 88.6 Curative (C) 2015-01-02 2015-01-03 Triple / Double Intrathecal Therapy N N 220018693 CARBOPLATIN + RT
220009546 220012085 1.8 103.4 Disease modification (D) 2017-08-04 2017-08-18 ALEMTUZUMAB + BUSULFAN + FLUDARABINE 2 N 220018755 CABOZANTINIB
220009547 220003893 null 95 Curative (C) 2017-08-09 2017-08-10 IBRUTINIB 02 N 220018780 FBC
220009548 220003893 1.66 56.6 Palliative (P) 2018-08-26 2018-08-26 CISPLATIN + ETOPOSIDE 2 N 220018780 LI-1 TRIAL
220009549 220003894 1.76 79.6 Palliative (P) null 2017-11-28 CISPLATIN + ETOPOSIDE N N 220019061 CARBO + FLUOROURACIL
220009550 220003895 1.64 67.9 Not known (9) 2017-12-02 2017-12-02 FEC + DOCETAXEL 2 N 220019679 CHOP
220009551 220003896 1.58 88.8 Curative (C) 2016-09-02 2016-09-10 ALL UKALL2011 IndB Std Dex (PegAsp) 2 N 220020055 ARSENIC TRIOXIDE + ATRA
220009552 220003897 1.68 null null 2017-12-20 2017-12-20 Arsenic trioxide + Tretinoin N N 220020101 FLUDARABINE